Clinical Competency Assessment
As the pandemic has become a catalyst for change, the College has been considering opportunities and assessment models to support candidates in their progression to Fellowship and will be considering a broader change in the theories and practice of assessment as a long-term strategy for the RANZCP.
After considerable discussion and stakeholder consultation, the Board has approved the implementation of the Clinical Competency Assessment (CCA), as a continuation of the Alternative Assessment Pathway (AAP) with some modifications, for the delivery for the remainder of 2022, and 2023.
There will be no OSCEs offered in 2022-2023.
The assessment comprises a Portfolio Review of completed In-Training Assessments (ITAs), and if required, a Case-based Discussion held via Zoom.
Under the Clinical Competency Assessment (CCA) to be offered in 2022 and 2023:
- All candidates are required to undergo a Portfolio Review.
- Candidates who are not able to demonstrate the required competency and standard via the Portfolio Review, will proceed to a Case-based Discussion (CbD).
The major changes from the current AAP process are:
- The Portfolio Review for trainees will require an assessment of their three (3) latest end-of-rotation ITAs, one of which must be a Stage 3 ITA of at least 6 months (FTE) duration. For SIMGs, there may be instances where only two end-of-rotation ITAs may be considered (as per the current Portfolio Review rules).
- Written case summaries will be assessed as part of the Communication domain of the CbD marking guide, and candidates will submit these if/when required.
The CCA will NOT be a ‘No-Disadvantage Exam’ - the results from this assessment will be reflected in the candidates’ training trajectory.
Results are published on the results, timetables fees page. Individual result letters are made available on InTrain.